Key|The 2nd
Hourly | Math 1107 | Fall Semester 2010
Protocol
You will use only the following
resources: Your individual calculator; individual tool-sheet (one (1) 8.5 by 11
inch sheet), writing utensils, blank paper (provided
by me) and this copy of the hourly.
Do not share these resources with
anyone else. Show complete detail and work for
full credit. Follow case study solutions
and sample hourly keys in presenting your solutions.
Work all four cases. Using only one side of the blank sheets provided,
present your work. Write on one side only of the sheets provided, and present
your work only on these sheets. Do not share information with any other
students during this hourly.
When you are finished:
Prepare a Cover Sheet: Print your name on an otherwise blank sheet of paper.
Then stack your stuff as follows: Cover Sheet (Top), Your Work Sheets,
The Test Papers, Your Toolsheet. Then hand all of this in to me.
Sign and Acknowledge: I agree
to follow this protocol.
Name (PRINTED) Signature Date
Case One | Descriptive
Statistics | Credit Scores
Fair Isaac Corporation
developed a consumer credit score, a number that summarizes the risk present in
lending money to a consumer. The consumer credit score ranges from 300 to 850.
Credit bureau scores are often called “FICO scores” because most credit bureau
scores used in the U.S. are produced from software developed by Fair Isaac and
Company. FICO scores are provided to lenders by the major credit reporting
agencies. Suppose that credit scores are
observed for a random sample of US residents taken in July of 2007:
350, 375, 450, 535, 576, 585, 590, 625, 640, 661, 669, 670, 673,
675, 679, 680, 685, 688, 691, 695, 700, 701 705, 706, 707, 713, 723, 727, 740,
743, 752, 755, 757, 759, 761, 774, 774, 775, 783, 785, 791, 794, 798, 801 805,
810, 815, 827, 830, 845
Compute
and interpret the following statistics: sample size, p00, p25, p50, p75, p100, (p100 – p25),
(p75 – p25), (p50 – p25).
n=50 | There are 50 US
residents in our sample, each contributing a July 2007 FICO score.
p0 = 350 | The lowest credit score in the sample was 350.
p25 = 673 |
Approximately 25% of the credit scores in the sample
were at 673 or lower.
p50 = 710 |
Approximately 50% of the credit scores in the sample
were at 710 or lower.
p75 = 775 |
Approximately 75% of the credit scores in the sample
were at 775 or lower.
p100 = 845
| The highest credit score in the sample was 845.
range41 = p100
– p25 = 845 – 673 = 172 | Approximately 75%
of the scores in the sample were between 673 and 845. The largest possible
difference in credit score between any pair of residents in the upper ¾ sample
is 172.
range31 = p75
– p25 = 775 – 673 = 102 | Approximately 50%
of the scores in the sample were between 673 and 775. The largest possible difference
in credit score between any pair of residents in the middle half sample is 102.
range21 = p50
– p25 = 710 – 673 = 37 | Approximately 25%
of the scores in the sample were between 673 and 710. The largest possible
difference in credit score between any pair of residents in the lower quarter
sample is 37.
Case
Two | Summary Intervals | Credit
Scores
Using the data and context of Case One, Let m denote the sample mean spot count, and sd the sample standard deviation. Compute and interpret the intervals m±2sd and m±3sd, using Tchebysheff’s
Inequalities and the Empirical Rule. Be specific and complete.
Show your work, and discuss completely for full credit.
lower2 = m – (2*sd) ≈ 702.96 – (2*106.19)
≈ 489.16 [489]
upper2 = m + (2*sd) ≈ 702.96 + (2*106.19)
≈ 916.76 [850]
lower3 = m – (3*sd) ≈ 702.96 – (3*106.19)
≈ 382.26 [383]
upper3 = m + (3*sd) ≈ 702.96 + (3*106.19)
≈ 1023.66 [850]
There are 50 FICO
credit scores in the sample, each drawn from a US resident during July of 2007.
At least 75% of the
credit scores in the sample are between 489 and 850.
At least 89% of the
credit scores in the sample are between 383 and 850.
If the FICO scores for
US residents for July 2007 cluster symmetrically around a central value,
becoming rare as distance from the center increases, then:
approximately 95% of the credit scores in the sample are
between 489 and 850 and approximately 100% of the credit scores in the sample
are between 383 and 850.
Case Three | Design
Fault Spot
In
each of the following a brief description of a design is presented. Briefly
identify faults present in the design. Use the information provided. Be brief
and complete.
3.1)
The objective of a sample survey is to study the attitudes of
urban business owners of the United States regarding federal programs, taxation
and spending. A random sample of urban residents is employed in this design. Assume
that there are no problems with the wording and delivery of the survey
instrument.
The survey must sample the appropriate target population –
owners of urban businesses. Not every urban resident owns an urban business,
and not urban business owner resides in the city.
3.2)
In
a comparative clinical trial,
treatment methods are compared in the treatment of Condition X, which when left
untreated leads to severe complications and possibly death. A new surgical
method is compared to a standard surgical method. Study physicians classify
subjects by the severity of their disease, and assign only the
"moderate" subjects to the new surgical method. Only the
"severe" subjects are assigned to the standard surgical method.
Randomly assign subjects to treatment without regard to disease
severity.
3.3)
A random sample of parents of college/university
first-year undergraduate students is surveyed about the study practices of
their children. The survey
questionnaire was properly written, and the sample of parents randomly and
reasonably selected. The parents responded to questions about their children's
study habits.
The survey must sample the appropriate target population – first-year
undergraduates. The parents need not be a reliable source of information
regarding their children’s study habits.
3.4)
In
a proposed clinical trial, treatment
methods are compared in the treatment of Condition Z, which when left untreated
leads to severe complications and possibly death. Suppose we have a new
candidate treatment, and further suppose that a standard treatment for a
similar (but different) disease is available. A comparative clinical trial is
proposed that would compare these treatments in patients with condition Z.
Use of the standard treatment(for a
different condition) is inappropriate for this trial, unless that treatment
also serves as a standard treatment for CZ, or if it is being considered an
experimental treatment for CZ. If a standard treatment for CZ is available, use
it – otherwise, use a placebo group as a basis for comparison.
Case
Four | Clinical Trial Sketch | Crohn's Disease
Crohn's
disease is a chronic inflammation of the intestinal wall. Most often, lower areas of the small
intestine (ileum) are involved, although any part of the digestive tract (from
the mouth to the anus) may be involved. Symptoms of Crohn's
disease include: chronic diarrhea, crampy abdominal
pain, fever, suppressed appetite and weight loss. Complications of Crohn's disease include: intestinal obstructions, abnormal
connections within the intestines, abnormal connections of the intestines and
bladder, abnormal connections of the intestines and the skin surface, and
intestinal infections. In children, symptoms may include joint inflammation,
slow growth, fever and anemia. Treatments of Crohn's
disease depend on the symptoms being treated. For infections, broad spectrum
anti-biotics are employed. For inflammation, cortico-steriods are used, as well as other anti-inflammatories. Additionally, certain medications focus on
the immune system for general symptom reduction, as well as keeping Crohn's disease in remission. Cortico-steroids
are used to provide relief for inflamed areas of the body. They lessen
swelling, redness, itching, and allergic reactions.
A standard treatment of Crohn’s disease is mesalamine, a
drug that reduces inflammation in the large intestine (colon). Budesonide is an orally administered, non-systemic cortico-steroid that is released in the intestine, where it
works locally and topically to decrease inflammation. Budenoside
is metabolized in a way that minimizes side effects. Hopefully, patients taking
budesonide experience fewer of the typical side
effects associated with other cortico-steroids used
to treat Crohn's Disease, such as prednisone or prednisolone tablets, because most of budesonide
is not absorbed into the body.
Possible side effects of cortico-steroids include: lowered resistance to infections,
persistent infections, decreased or blurred vision; frequent urination;
increased thirst, abdominal or stomach pain or burning, headache; irregular
heartbeat; menstrual problems; muscle cramps or pain; muscle weakness; nausea.
Sketch a comparative clinical trial
for budesonide versus mesalamine
in the treatment of large intestinal
(colon) inflammation in patients with Crohn's
disease. Make your sketch concise and complete, following the style
demonstrated in class, in the sample second hourlies
and in case study summaries.
A Comparison of Budesonide
and Mesalamine for Active Crohn's
Disease (N Engl J Med
1998:339;370 - 374)
We recruit subjects with Chrohn’s
disease affecting the large intestine/colon. Those giving informed consent and
who meet appropriate inclusion and exclusion criteria are enrolled in the
trial.
Enrolled subjects are randomly assigned to either Budesonide with PlaceboMesalamine
or to PlaceboBudesonide + Mesalamine. Double-blinding is employed, so that neither
the subjects nor the clinical workers know individual treatment status.
Treated subjects are followed for toxicity(organ damage,
especially kidney/liver),
side effects (including lowered resistance to infections,
persistent infections, decreased or blurred vision; frequent urination;
increased thirst, abdominal or stomach pain or burning, headache; irregular
heartbeat; menstrual problems; muscle cramps or pain; muscle weakness; nausea)
and
effectiveness (including chronic diarrhea, crampy
abdominal pain, fever, suppressed appetite and weight loss. Complications of Crohn's disease include: intestinal obstructions, abnormal
connections within the intestines, abnormal connections of the intestines and
bladder, abnormal connections of the intestines and the skin surface, and
intestinal infections. In children, symptoms may include joint inflammation,
slow growth, fever and anemia). Quality of life may also be considered.
Work
all four (4) cases.